Results: We found a progressively higher dietary GI to be associated with increasing odds of incident depression in fully adjusted models (OR for the fifth compared with first quintile: 1.22; 95% CI: 1.09, 1.37), with the trend being statistically significant (P = 0.0032). Progressively higher consumption of dietary added sugars was also associated with increasing odds of incident depression (OR for the fifth compared with first quintile: 1.23; 95% CI: 1.07, 1.41; P-trend = 0.0029). Higher consumption of lactose, fiber, nonjuice fruit, and vegetables was significantly associated with lower odds of incident depression, and nonwhole/refined grain consumption was associated with increased odds of depression.
As seen in previous studies, patients with elevated depressive symptoms had a higher risk of MI or all-cause death through about 4 years of follow-up, after accounting for demographics, education, income, and body mass index HR 1.41, 95% CI 1.15 to 1.72, according to Siqin Ye, MD, of Columbia University in New York City, and colleagues.
No scary chart needed for this awful number.
Vilazodone (Viibryd) has been approved for treatment of major depression, the FDA announced.
Women who had diabetes had about a 35 percent increased risk of dying, and those with depression had about a 44 percent increased risk, compared with women with neither condition, the researchers calculated.
Those with both conditions had about twice the risk of dying, the study authors found.
The risk of all-cause mortality was elevated 67% for patients with coronary heart disease (P<0.05) and 2.10 times for those with depressive symptoms (P<0.001) in the long-running Whitehall II study of British civil servants.
But patients who had both conditions had a nearly five-fold risk compared with those who had neither (hazard ratio 4.99, P<0.001), Hermann Nabi, PhD, of the University of Versailles, France, and colleagues reported online in Heart.